DexCom, Inc. (DXCM)
DexCom Market Cap : 25.13B for May 18, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Insulet Corp. | 10.56B |
| Abbott Laboratories | 153.06B |
| Tandem Diabetes Care, Inc. | 926.51M |
| Intuitive Surgical, Inc. | 155.78B |
| Medtronic Plc | 99.26B |
Market Cap Related Metrics
| PE Ratio | 27.85 |
| PS Ratio | 5.434 |
| PEG Ratio | 0.3687 |
| Price to Book Value | 8.497 |
| Price to Free Cash Flow | 18.31 |
| Price | 65.12 |
| Earnings Yield | 3.59% |
| PEGY Ratio | 0.3687 |
| Operating PE Ratio | 25.33 |
| Normalized PE Ratio | 27.85 |